LONDON: AstraZeneca and British Prime Minister Boris Johnson on Thursday defended the effectiveness of the company’s Covid-19 vaccine after regulators in Germany said it should not be given to over-65s.
A spokesperson for the UK-based company said the latest clinical trial data for its vaccine, developed with Oxford University, “support efficacy in the over 65 years age group.”
The company is awaiting a decision from the EU’s medicines regulator, the spokesperson added.
Johnson meanwhile told reporters that the UK’s own regulator had established “that they think the Oxford/AstraZeneca vaccine is very good and efficacious, gives a high degree of protection.”
A panel of scientific experts in Germany said the vaccine should only be used for “persons aged 18 to 65 years old based on available data,” citing “insufficient data” to assess its efficacy for older people.
Britain has been using the Oxford/AstraZeneca jab along with another developed by Pfizer/BioNTech across all older age groups as it bids to immunize the most vulnerable 15 million people by mid-February.
Mary Ramsay, head of immunizations at the government agency Public Health England, also backed the AstraZeneca vaccine for older recipients.
“Both the AstraZeneca and Pfizer/BioNTech vaccines are safe and provide high levels of protection against Covid-19, particularly against severe disease,” she said.
“There were too few cases in older people in the AstraZeneca trials to observe precise levels of protection in this group, but data on immune responses were very reassuring,” Ramsay added.
“The risk of severe disease and death increase exponentially with age — the priority is to vaccinate as many vulnerable people as possible with either vaccine, to protect more people and save more lives.”
AstraZeneca, UK PM defend COVID jab’s effectiveness
Short Url
https://arab.news/59wky
AstraZeneca, UK PM defend COVID jab’s effectiveness
- The AstraZeneca vaccine's efficacy among over-65s was called into question by German regulators
- Britain has been using the shot as a core part of its nationwide vaccination program
Discussions with Board of Peace ‘on hold’ due to Iran war, Indonesia says
JAKARTA: Indonesia’s foreign minister said talks on US President Donald Trump’s Gaza “Board of Peace,” of which the Southeast Asian nation is a key troop-contributing member, were on hold due to the Middle East war.
The US and Israeli air war against Iran has killed scores of civilians, thrown global air transport into chaos and sent oil prices surging after the effective closure of the Strait of Hormuz.
“All BoP discussions are on hold as all attention has shifted to the situation in Iran,” Minister Sugiono, who goes by one name, said late on Tuesday in response to a question on calls for Indonesia to exit the peace board in the aftermath of the fresh conflict in the Middle East.
“We will also consult with our friends and colleagues in the Gulf because they are also under attack,” Sugiono told reporters after attending an event alongside President Prabowo Subianto.
Indonesia’s participation on the board has drawn criticism from experts and Muslim groups at home, who say it compromises the world’s largest Muslim-majority nation’s longstanding support for the Palestinian cause.
Indonesia backs a two-state solution.
The Indonesian Ulema Council, a leading clerical body, said on March 1 that Indonesia should leave the board, citing Trump’s attack on Iran as rendering the initiative ineffective.
Meanwhile, Nahdlatul Ulama, Indonesia’s largest Muslim organization, said Jakarta should use its position to press Israel and the United States to halt the violence.
Trump first proposed the board in September when he unveiled a plan to end Israel’s war in Gaza, later expanding its remit to address other global conflicts typically handled by the United Nations.
Sugiono also said Prabowo is willing to be a mediator in the Iran war in a bid “to cool down and de-escalate the situation in the region.”
Indonesia is readying 1,000 troops for potential deployment in Gaza by early April as part of a proposed multinational peacekeeping force, its army said, as part of the UN-mandated International Stabilization Force. It has also been given the deputy commander role of the force.
The US and Israeli air war against Iran has killed scores of civilians, thrown global air transport into chaos and sent oil prices surging after the effective closure of the Strait of Hormuz.
“All BoP discussions are on hold as all attention has shifted to the situation in Iran,” Minister Sugiono, who goes by one name, said late on Tuesday in response to a question on calls for Indonesia to exit the peace board in the aftermath of the fresh conflict in the Middle East.
“We will also consult with our friends and colleagues in the Gulf because they are also under attack,” Sugiono told reporters after attending an event alongside President Prabowo Subianto.
Indonesia’s participation on the board has drawn criticism from experts and Muslim groups at home, who say it compromises the world’s largest Muslim-majority nation’s longstanding support for the Palestinian cause.
Indonesia backs a two-state solution.
The Indonesian Ulema Council, a leading clerical body, said on March 1 that Indonesia should leave the board, citing Trump’s attack on Iran as rendering the initiative ineffective.
Meanwhile, Nahdlatul Ulama, Indonesia’s largest Muslim organization, said Jakarta should use its position to press Israel and the United States to halt the violence.
Trump first proposed the board in September when he unveiled a plan to end Israel’s war in Gaza, later expanding its remit to address other global conflicts typically handled by the United Nations.
Sugiono also said Prabowo is willing to be a mediator in the Iran war in a bid “to cool down and de-escalate the situation in the region.”
Indonesia is readying 1,000 troops for potential deployment in Gaza by early April as part of a proposed multinational peacekeeping force, its army said, as part of the UN-mandated International Stabilization Force. It has also been given the deputy commander role of the force.
© 2026 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.










